|

Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy

RECRUITINGSponsored by Masonic Cancer Center, University of Minnesota
Actively Recruiting
SponsorMasonic Cancer Center, University of Minnesota
Started2024-02-08
Est. completion2027-07-21
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06414278

Summary

This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* \* ≥ 18 years of age at initiation of therapy

  * Planning to undergo inpatient CAR-T therapy for primary malignancy
  * Fluent in English (written or spoken)

Exclusion Criteria:

* \* Subjects with speech or hearing impediment that would make them unable to be assessed with SALSA

  * Subjects with diagnosed cognitive impairment prior to CAR-T therapy
  * Unwilling or unable to sign voluntary written consent

Conditions3

CancerHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Locations1 site

University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, 55455
Veronika Bachanova612-625-5469bach0173@umn.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.